BioMed X and Sanofi partner to leverage AI for drug development
Pharmaceutical Technology
OCTOBER 25, 2022
BioMed X has entered a research partnership with Sanofi to leverage artificial intelligence (AI) for drug development. The companies will jointly create a virtual patient engine for the drug candidates’ clinical translation. The companies will jointly create a virtual patient engine for the drug candidates’ clinical translation.
Let's personalize your content